Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 1061 | 4.050 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 45 | 3.490 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 321 | 3.260 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 2109 | 2.640 |
Why?
|
| Life Expectancy | 9 | 2022 | 28 | 2.450 |
Why?
|
| Obesity | 10 | 2020 | 310 | 2.300 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 100 | 2.230 |
Why?
|
| Aged | 62 | 2025 | 8979 | 1.800 |
Why?
|
| Body Mass Index | 13 | 2024 | 457 | 1.770 |
Why?
|
| Prospective Studies | 31 | 2025 | 1771 | 1.710 |
Why?
|
| Risk Factors | 31 | 2025 | 2295 | 1.600 |
Why?
|
| Female | 66 | 2025 | 15166 | 1.570 |
Why?
|
| Exercise | 13 | 2022 | 450 | 1.540 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 263 | 1.530 |
Why?
|
| Humans | 91 | 2025 | 26946 | 1.500 |
Why?
|
| Male | 58 | 2025 | 14718 | 1.480 |
Why?
|
| Netherlands | 18 | 2024 | 26 | 1.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 167 | 1.350 |
Why?
|
| Cognition | 15 | 2024 | 1339 | 1.290 |
Why?
|
| Independent Living | 6 | 2025 | 322 | 1.130 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 44 | 1.120 |
Why?
|
| Cohort Studies | 21 | 2025 | 1882 | 1.100 |
Why?
|
| Aging | 11 | 2025 | 1541 | 1.100 |
Why?
|
| Mothers | 2 | 2018 | 186 | 1.010 |
Why?
|
| Stroke | 5 | 2023 | 261 | 1.000 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 125 | 0.930 |
Why?
|
| Chicago | 16 | 2025 | 950 | 0.890 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.880 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 4771 | 0.830 |
Why?
|
| Vitamin D | 2 | 2022 | 39 | 0.820 |
Why?
|
| Middle Aged | 30 | 2024 | 8887 | 0.800 |
Why?
|
| DNA Methylation | 6 | 2021 | 161 | 0.780 |
Why?
|
| Dementia | 6 | 2024 | 559 | 0.770 |
Why?
|
| Risk Assessment | 7 | 2024 | 626 | 0.750 |
Why?
|
| Overweight | 5 | 2021 | 72 | 0.730 |
Why?
|
| Blood Pressure | 3 | 2024 | 194 | 0.720 |
Why?
|
| Epigenomics | 4 | 2021 | 19 | 0.720 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1368 | 0.710 |
Why?
|
| Menopause | 5 | 2024 | 101 | 0.700 |
Why?
|
| United States | 9 | 2024 | 2034 | 0.650 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 36 | 0.640 |
Why?
|
| Brain | 6 | 2024 | 1649 | 0.630 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.610 |
Why?
|
| Incidence | 9 | 2025 | 758 | 0.610 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 24 | 0.600 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 58 | 0.600 |
Why?
|
| Mortality | 2 | 2016 | 89 | 0.590 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.590 |
Why?
|
| Patient Compliance | 1 | 2018 | 150 | 0.550 |
Why?
|
| Lipids | 3 | 2025 | 50 | 0.550 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 17 | 0.530 |
Why?
|
| Biomarkers | 8 | 2025 | 561 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 346 | 0.520 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.520 |
Why?
|
| Life Style | 4 | 2022 | 186 | 0.520 |
Why?
|
| Body Composition | 1 | 2016 | 68 | 0.500 |
Why?
|
| Anthropometry | 1 | 2015 | 34 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 232 | 0.480 |
Why?
|
| Alleles | 4 | 2024 | 216 | 0.480 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.470 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1784 | 0.420 |
Why?
|
| Postmenopause | 3 | 2018 | 54 | 0.390 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 279 | 0.390 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 18 | 0.390 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 40 | 0.380 |
Why?
|
| Environmental Exposure | 2 | 2024 | 17 | 0.380 |
Why?
|
| Diet | 5 | 2024 | 219 | 0.370 |
Why?
|
| Air Pollution | 2 | 2024 | 14 | 0.370 |
Why?
|
| CpG Islands | 4 | 2021 | 53 | 0.360 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 75 | 0.360 |
Why?
|
| Adult | 11 | 2024 | 7793 | 0.360 |
Why?
|
| Atherosclerosis | 3 | 2022 | 53 | 0.360 |
Why?
|
| White Matter | 2 | 2022 | 134 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 381 | 0.320 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1140 | 0.320 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 86 | 0.300 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 90 | 0.300 |
Why?
|
| Pandemics | 2 | 2020 | 236 | 0.300 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 20 | 0.300 |
Why?
|
| Population Surveillance | 2 | 2021 | 115 | 0.290 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 250 | 0.290 |
Why?
|
| Coronary Disease | 2 | 2018 | 50 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 43 | 0.290 |
Why?
|
| Body Size | 2 | 2019 | 11 | 0.290 |
Why?
|
| Dietary Supplements | 3 | 2022 | 66 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 38 | 0.270 |
Why?
|
| Adolescent | 4 | 2024 | 2156 | 0.270 |
Why?
|
| Child | 3 | 2024 | 1290 | 0.260 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 5 | 0.260 |
Why?
|
| Prevalence | 3 | 2023 | 441 | 0.260 |
Why?
|
| Sex Factors | 5 | 2020 | 461 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 13 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 83 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 324 | 0.240 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.240 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 135 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.240 |
Why?
|
| Beverages | 1 | 2024 | 12 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 18 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 30 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 59 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 39 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 64 | 0.220 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.220 |
Why?
|
| Florida | 1 | 2023 | 17 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 159 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 278 | 0.210 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vitamin E | 1 | 2023 | 44 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Betacoronavirus | 2 | 2020 | 74 | 0.200 |
Why?
|
| Comorbidity | 3 | 2022 | 479 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1429 | 0.200 |
Why?
|
| Smoking | 3 | 2020 | 174 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 30 | 0.190 |
Why?
|
| Lutein | 1 | 2021 | 5 | 0.190 |
Why?
|
| Zeaxanthins | 1 | 2021 | 5 | 0.190 |
Why?
|
| Carotenoids | 1 | 2021 | 18 | 0.190 |
Why?
|
| Survivors | 1 | 2022 | 70 | 0.190 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 23 | 0.190 |
Why?
|
| Diet Surveys | 1 | 2021 | 25 | 0.190 |
Why?
|
| Leukocytes | 1 | 2021 | 33 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 218 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 42 | 0.180 |
Why?
|
| Diet, Western | 1 | 2021 | 11 | 0.180 |
Why?
|
| Body Weight | 2 | 2018 | 134 | 0.180 |
Why?
|
| Amyloid | 1 | 2021 | 56 | 0.180 |
Why?
|
| Weight Loss | 2 | 2020 | 127 | 0.180 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lipase | 1 | 2020 | 4 | 0.170 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 16 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 16 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 165 | 0.170 |
Why?
|
| Pancreas | 1 | 2020 | 32 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 312 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 43 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 1196 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 16 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 127 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 207 | 0.170 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 3 | 0.170 |
Why?
|
| Consanguinity | 1 | 2019 | 4 | 0.170 |
Why?
|
| Neoplasms | 2 | 2020 | 237 | 0.170 |
Why?
|
| Fertility | 1 | 2019 | 18 | 0.170 |
Why?
|
| Autopsy | 1 | 2021 | 344 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 26 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 34 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 38 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 34 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 302 | 0.150 |
Why?
|
| Androgens | 1 | 2018 | 8 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2017 | 50 | 0.150 |
Why?
|
| Child Behavior | 1 | 2018 | 27 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 45 | 0.150 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 11 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 63 | 0.150 |
Why?
|
| Asthma | 1 | 2020 | 156 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 28 | 0.150 |
Why?
|
| Basal Metabolism | 1 | 2018 | 8 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 474 | 0.150 |
Why?
|
| Testosterone | 1 | 2018 | 28 | 0.150 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.150 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.150 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.150 |
Why?
|
| Nitrates | 1 | 2017 | 9 | 0.150 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 301 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 94 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 14 | 0.140 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 15 | 0.140 |
Why?
|
| Protective Factors | 4 | 2018 | 26 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2017 | 25 | 0.140 |
Why?
|
| Transportation | 1 | 2016 | 4 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 5 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 335 | 0.140 |
Why?
|
| Histones | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 29 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 10 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 100 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 5 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 6 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2018 | 639 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 587 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 55 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 890 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2022 | 985 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 76 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 60 | 0.120 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 11 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 159 | 0.120 |
Why?
|
| Perimenopause | 1 | 2014 | 15 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 261 | 0.120 |
Why?
|
| Copper | 2 | 2024 | 18 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 479 | 0.110 |
Why?
|
| Risk | 3 | 2018 | 203 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 781 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 326 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 759 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 61 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 64 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 346 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 46 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 293 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 22 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 253 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 288 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 8 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 6 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 42 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 42 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 100 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 83 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2024 | 85 | 0.060 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 11 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 16 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 191 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 8 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 22 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 75 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 58 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 97 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 8 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 47 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 56 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 26 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 199 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 89 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 111 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 3 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 22 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 19 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 20 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 79 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 58 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 33 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 102 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 28 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 20 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 94 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 6 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 104 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3627 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 34 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 7 | 0.040 |
Why?
|
| Life Tables | 1 | 2017 | 4 | 0.040 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.040 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.040 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 215 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 38 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 121 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 56 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 877 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 29 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 345 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 395 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 49 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 50 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 255 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 268 | 0.030 |
Why?
|
| Health | 1 | 2016 | 10 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 175 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 3 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 68 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 102 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 14 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 148 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 154 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 53 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 79 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 79 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 62 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 174 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 177 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 156 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 371 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 271 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 683 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 443 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3454 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 670 | 0.020 |
Why?
|